Researcher awarded grant from Rally Foundation Childhood Cancer Research
The 20/20: Alumni Visionary Grant is part of the Rally Foundation for Childhood Cancer Research's 2026 record-breaking $7 million grant distribution.
What's New
Our newsroom features all of the latest news, publications and media coverage for the Pediatric Immunotherapy Program.
Â鶹AV recognized in inaugural Cure Innovation Index
Â鶹AV placed No. 86 among 243 universities in the United States and was recognized as Top 5 in Georgia.
David Munn, MD, appointed director of the Georgia Cancer Center
David Munn, MD, is internationally recognized for research that revealed how tumors manipulate the immune system and translating those insights into therapeutic strategies.Â
Hyundai invests $400,000 in pediatric cancer research at Â鶹AV
"We really rely on people like Hyundai who understand the need and give hope to these kids," says David Munn, MD.